4basebio PLC

XTER:88Q (UK)   Ordinary Shares
€ 14.30 (-0.69%) Dec 20
At Loss
Market Cap:
€ 221.02M ($ 229.74M)
Enterprise V:
€ 229.92M ($ 239.12M)
Volume:
853.00
Avg Vol (2M):
1.38K
Trade In:
Volume:
853.00
At Loss

Business Description

Description
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.
Name Current Vs Industry Vs History
Cash-To-Debt 0.26
Equity-to-Asset -0.44
Debt-to-Equity -2
Debt-to-EBITDA -1.14
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.86
Distress
Grey
Safe
Beneish M-Score -2.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 29.49
9-Day RSI 29.03
14-Day RSI 28.36
6-1 Month Momentum % -17.11
12-1 Month Momentum % 102.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.73
Quick Ratio 2.53
Cash Ratio 1.51
Days Inventory 600.27
Days Sales Outstanding 44.71
Days Payable 1355.81

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -4.27

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 69.63
Operating Margin % -1711.58
Net Margin % -1650.67
FCF Margin % -1641.77
ROE % -231.29
ROA % -83.36
ROIC % -116.19
ROC (Joel Greenblatt) % -236.8
ROCE % -101.41

Financials (Next Earnings Date:2025-06-05 Est.)

XTER:88Q's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

4basebio PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.699
EPS (TTM) (€) -0.915
Beta 0.67
Volatility % 43.26
14-Day RSI 28.36
14-Day ATR (€) 0.240428
20-Day SMA (€) 14.925
12-1 Month Momentum % 102.61
52-Week Range (€) 7.5 - 21.2
Shares Outstanding (Mil) 15.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

4basebio PLC Filings

Filing Date Document Date Form
No Filing Data

4basebio PLC Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

4basebio PLC Frequently Asked Questions

What is 4basebio PLC(XTER:88Q)'s stock price today?
The current price of XTER:88Q is €14.30. The 52 week high of XTER:88Q is €21.20 and 52 week low is €7.50.
When is next earnings date of 4basebio PLC(XTER:88Q)?
The next earnings date of 4basebio PLC(XTER:88Q) is 2025-06-05 Est..
Does 4basebio PLC(XTER:88Q) pay dividends? If so, how much?
4basebio PLC(XTER:88Q) does not pay dividend.

Press Release

Subject Date
No Press Release